Gene symbol   |
Time course plot |
Accession |
Description |
Treatment |
15min |
30min |
1hr |
2hr |
4hr |
8hr |
20hr |
2310005E 10Rik |  |
BC026843 |
RIKEN cDNA 2310005E10 gene, mRNA (cDNA clone IMAGE:4487182), complete cds. [BC026843] |
KLA | .70 |
.65 |
.65 |
.65 |
.83 |
.90 |
.89 |
| ATP | 1.00 |
.95 |
.75 |
.31 |
.29 |
.58 |
.80 |
| KLA/ATP | .69 |
.54 |
.49 |
.28 |
.36 |
.56 |
.53 |
|
2310005E 10Rik |  |
NM_172398 |
RIKEN cDNA 2310005E10 gene (2310005E10Rik), mRNA [NM_172398] |
KLA | .78 |
.71 |
.71 |
.71 |
.69 |
.90 |
.82 |
| ATP | 1.01 |
.95 |
1.18 |
.89 |
.68 |
.44 |
.62 |
| KLA/ATP | .71 |
.70 |
.88 |
.67 |
.60 |
.59 |
.63 |
|
6720408I 04Rik |  |
AK020107 |
12 days embryo male wolffian duct includes surrounding region cDNA, RIKEN full-length enriched library, clone:6720408I04 product:hypothetical protein, full insert sequence. [AK020107] |
KLA | .92 |
1.01 |
1.02 |
.96 |
.93 |
1.00 |
.99 |
| ATP | 1.00 |
.94 |
.90 |
.94 |
1.01 |
1.01 |
.98 |
| KLA/ATP | 1.00 |
.95 |
.92 |
.94 |
1.01 |
.97 |
.95 |
|
A530057A 03Rik |  |
NM_001081089 |
RIKEN cDNA A530057A03 gene (A530057A03Rik), mRNA [NM_001081089] |
KLA | 1.06 |
1.10 |
1.05 |
1.03 |
1.12 |
1.14 |
1.27 |
| ATP | 1.04 |
1.11 |
1.07 |
1.01 |
.97 |
.99 |
1.06 |
| KLA/ATP | 1.10 |
1.19 |
1.14 |
.96 |
1.11 |
.91 |
1.09 |
|
AK165218
|  |
AK165218 |
6 days neonate spleen cDNA, RIKEN full-length enriched library, clone:F420008K05 product:lipin 2, full insert sequence. [AK165218] |
KLA | .96 |
.94 |
.83 |
1.03 |
1.08 |
.97 |
1.07 |
| ATP | 1.20 |
1.84 |
1.52 |
2.12 |
1.12 |
1.23 |
1.14 |
| KLA/ATP | .97 |
1.03 |
1.17 |
1.13 |
.98 |
1.07 |
1.21 |
|
Agk |  |
NM_023538 |
acylglycerol kinase (Agk), mRNA [NM_023538] |
KLA | 1.16 |
1.30 |
1.23 |
1.15 |
.96 |
.85 |
.86 |
| ATP | .97 |
.99 |
.99 |
1.04 |
.92 |
.88 |
.81 |
| KLA/ATP | 1.15 |
1.25 |
1.25 |
1.39 |
1.09 |
.93 |
.56 |
|
Agpat1 |  |
NM_018862 |
1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha) (Agpat1), mRNA [NM_018862] |
KLA | 1.24 |
1.27 |
1.16 |
1.37 |
1.37 |
1.51 |
1.65 |
| ATP | .99 |
1.09 |
1.19 |
1.29 |
1.20 |
1.03 |
1.27 |
| KLA/ATP | 1.27 |
1.33 |
1.37 |
1.49 |
1.28 |
1.17 |
1.55 |
|
Agpat2 |  |
NM_026212 |
1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta) (Agpat2), mRNA [NM_026212] |
KLA | .88 |
.86 |
1.05 |
1.00 |
1.28 |
1.13 |
1.05 |
| ATP | 1.06 |
1.15 |
.95 |
1.09 |
.97 |
1.22 |
1.04 |
| KLA/ATP | .96 |
.94 |
.73 |
.87 |
.78 |
.97 |
.63 |
|
Agpat3 |  |
NM_053014 |
1-acylglycerol-3-phosphate O-acyltransferase 3 (Agpat3), mRNA [NM_053014] |
KLA | 1.13 |
1.10 |
1.05 |
1.19 |
1.28 |
1.33 |
1.53 |
| ATP | .95 |
.95 |
.89 |
.84 |
.79 |
.82 |
1.41 |
| KLA/ATP | .95 |
1.03 |
1.08 |
.94 |
.77 |
.75 |
1.42 |
|
Agpat4 |  |
NM_026644 |
1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta) (Agpat4), mRNA [NM_026644] |
KLA | 1.37 |
1.26 |
1.06 |
1.10 |
.98 |
1.29 |
1.77 |
| ATP | 1.05 |
.95 |
1.02 |
1.26 |
1.86 |
3.88 |
2.42 |
| KLA/ATP | 1.38 |
1.32 |
1.44 |
1.22 |
1.29 |
2.06 |
5.07 |
|
Agpat6 |  |
NM_018743 |
1-acylglycerol-3-phosphate O-acyltransferase 6 (lysophosphatidic acid acyltransferase, zeta) (Agpat6), mRNA [NM_018743] |
KLA | 1.14 |
1.08 |
1.21 |
1.15 |
1.17 |
1.25 |
1.50 |
| ATP | 1.05 |
1.02 |
.91 |
.91 |
1.11 |
1.42 |
1.26 |
| KLA/ATP | 1.16 |
1.17 |
.96 |
.87 |
1.00 |
1.40 |
1.35 |
|
Agpat9 |  |
NM_172715 |
1-acylglycerol-3-phosphate O-acyltransferase 9 (Agpat9), transcript variant 1, mRNA [NM_172715] |
KLA | .69 |
.70 |
.67 |
.64 |
.61 |
.61 |
.79 |
| ATP | .89 |
.77 |
.69 |
.57 |
2.26 |
2.30 |
1.90 |
| KLA/ATP | .67 |
.66 |
.68 |
.56 |
1.39 |
1.82 |
1.98 |
|
Akr1a4 |  |
NM_021473 |
aldo-keto reductase family 1, member A4 (aldehyde reductase) (Akr1a4), mRNA [NM_021473] |
KLA | .96 |
1.00 |
1.13 |
.96 |
1.13 |
1.16 |
1.43 |
| ATP | 1.06 |
1.07 |
.77 |
.94 |
.86 |
1.17 |
2.12 |
| KLA/ATP | 1.06 |
1.03 |
.65 |
.93 |
.85 |
1.38 |
2.61 |
|
Akr1b3 |  |
AK054167 |
2 days pregnant adult female oviduct cDNA, RIKEN full-length enriched library, clone:E230024H01 product:unclassifiable, full insert sequence [AK054167] |
KLA | 1.06 |
.92 |
.98 |
1.01 |
1.02 |
1.04 |
.96 |
| ATP | 1.08 |
1.02 |
.99 |
.97 |
1.09 |
1.02 |
.99 |
| KLA/ATP | .99 |
1.01 |
.97 |
.99 |
1.02 |
.99 |
1.08 |
|
Akr1b3 |  |
NM_009658 |
aldo-keto reductase family 1, member B3 (aldose reductase) (Akr1b3), mRNA [NM_009658] |
KLA | .97 |
.99 |
.96 |
.91 |
.92 |
.93 |
.77 |
| ATP | 1.08 |
1.13 |
1.09 |
1.15 |
1.00 |
1.03 |
1.18 |
| KLA/ATP | 1.06 |
.98 |
.95 |
1.15 |
.89 |
.88 |
.82 |
|
Akr1b7 |  |
NM_009731 |
aldo-keto reductase family 1, member B7 (Akr1b7), mRNA [NM_009731] |
KLA | .92 |
.93 |
.93 |
.93 |
.97 |
.96 |
.84 |
| ATP | .97 |
1.01 |
.93 |
.88 |
.85 |
.95 |
.88 |
| KLA/ATP | .86 |
.92 |
.92 |
.82 |
.85 |
.94 |
1.02 |
|
Akr1b8 |  |
NM_008012 |
aldo-keto reductase family 1, member B8 (Akr1b8), mRNA [NM_008012] |
KLA | .64 |
.56 |
.49 |
.46 |
.31 |
.25 |
.25 |
| ATP | .95 |
.97 |
1.17 |
.90 |
.85 |
2.25 |
2.02 |
| KLA/ATP | .55 |
.53 |
.63 |
.47 |
.50 |
1.00 |
2.18 |
|
Aldh1b1 |  |
NM_028270 |
aldehyde dehydrogenase 1 family, member B1 (Aldh1b1), nuclear gene encoding mitochondrial protein, mRNA [NM_028270] |
KLA | 7.51 |
7.83 |
9.27 |
11.57 |
11.10 |
10.78 |
4.79 |
| ATP | .93 |
.91 |
.90 |
.89 |
.73 |
2.27 |
2.30 |
| KLA/ATP | 6.45 |
7.40 |
9.33 |
9.54 |
8.82 |
12.15 |
10.67 |
|
Aldh2 |  |
AK163452 |
adult male corpora quadrigemina cDNA, RIKEN full-length enriched library, clone:B230105J09 product:aldehyde dehydrogenase 2, mitochondrial, full insert sequence [AK163452] |
KLA | .62 |
.65 |
.59 |
.60 |
.63 |
.64 |
.49 |
| ATP | 1.01 |
.91 |
1.06 |
.93 |
1.18 |
.93 |
.41 |
| KLA/ATP | .70 |
.68 |
.70 |
.84 |
1.16 |
.96 |
.45 |
|
Aldh2 |  |
NM_009656 |
aldehyde dehydrogenase 2, mitochondrial (Aldh2), nuclear gene encoding mitochondrial protein, mRNA [NM_009656] |
KLA | .74 |
.81 |
.77 |
.65 |
.60 |
.53 |
.50 |
| ATP | .98 |
1.10 |
.90 |
1.17 |
1.04 |
.82 |
.60 |
| KLA/ATP | .84 |
.86 |
.77 |
.82 |
.72 |
.66 |
.51 |
|
Aldh3a2 |  |
NM_007437 |
aldehyde dehydrogenase family 3, subfamily A2 (Aldh3a2), mRNA [NM_007437] |
KLA | .86 |
.83 |
.79 |
.79 |
.80 |
.97 |
1.00 |
| ATP | .93 |
.98 |
.94 |
.89 |
.77 |
.87 |
1.02 |
| KLA/ATP | .78 |
.81 |
.67 |
.72 |
.65 |
.81 |
.97 |
|
Aldh7a1 |  |
NM_138600 |
aldehyde dehydrogenase family 7, member A1 (Aldh7a1), mRNA [NM_138600] |
KLA | .98 |
1.03 |
1.08 |
1.12 |
1.08 |
.94 |
.99 |
| ATP | 1.01 |
1.03 |
1.00 |
1.03 |
.98 |
.82 |
.91 |
| KLA/ATP | 1.15 |
1.12 |
1.01 |
1.02 |
.90 |
.89 |
.83 |
|
Aldh9a1 |  |
NM_019993 |
aldehyde dehydrogenase 9, subfamily A1 (Aldh9a1), mRNA [NM_019993] |
KLA | .64 |
.64 |
.67 |
.48 |
.42 |
.24 |
.33 |
| ATP | 1.07 |
1.02 |
.75 |
.94 |
.68 |
.46 |
.42 |
| KLA/ATP | .72 |
.65 |
.43 |
.55 |
.37 |
.31 |
.24 |
|
Cel |  |
NM_009885 |
carboxyl ester lipase (Cel), mRNA [NM_009885] |
KLA | 1.06 |
1.02 |
1.06 |
1.07 |
1.07 |
1.08 |
1.11 |
| ATP | 1.01 |
1.04 |
1.18 |
1.09 |
1.09 |
1.21 |
1.09 |
| KLA/ATP | 1.06 |
.97 |
1.24 |
1.16 |
1.19 |
1.21 |
1.10 |
|
Dak |  |
NM_145496 |
dihydroxyacetone kinase 2 homolog (yeast) (Dak), mRNA [NM_145496] |
KLA | 1.00 |
1.03 |
1.04 |
.98 |
1.06 |
.90 |
.85 |
| ATP | 1.13 |
1.16 |
.89 |
1.01 |
.74 |
.67 |
.85 |
| KLA/ATP | 1.07 |
1.07 |
.90 |
.98 |
.66 |
.56 |
.81 |
|
Dgat1 |  |
NM_010046 |
diacylglycerol O-acyltransferase 1 (Dgat1), mRNA [NM_010046] |
KLA | 1.05 |
1.03 |
1.09 |
.93 |
1.04 |
1.06 |
1.42 |
| ATP | 1.06 |
1.12 |
1.23 |
1.57 |
1.34 |
2.37 |
1.50 |
| KLA/ATP | 1.11 |
1.10 |
.97 |
1.24 |
1.10 |
2.12 |
2.03 |
|
Dgat2 |  |
NM_026384 |
diacylglycerol O-acyltransferase 2 (Dgat2), mRNA [NM_026384] |
KLA | 2.44 |
2.65 |
2.86 |
3.52 |
3.45 |
2.83 |
1.41 |
| ATP | .97 |
.97 |
1.07 |
1.81 |
1.69 |
2.29 |
1.29 |
| KLA/ATP | 2.21 |
2.45 |
2.36 |
2.76 |
3.16 |
4.51 |
3.63 |
|
Dgka |  |
NM_016811 |
diacylglycerol kinase, alpha (Dgka), mRNA [NM_016811] |
KLA | 3.34 |
3.15 |
3.23 |
3.20 |
2.95 |
1.29 |
.45 |
| ATP | 1.11 |
.97 |
1.01 |
.90 |
1.32 |
1.39 |
1.33 |
| KLA/ATP | 2.97 |
3.42 |
3.95 |
2.85 |
2.49 |
1.47 |
1.21 |
|
Dgkb |  |
AK032509 |
adult male olfactory brain cDNA, RIKEN full-length enriched library, clone:6430574F24 product:DIACYLGLYCEROL KINASE, BETA (EC 2.7.1.107) (DIGLYCERIDE KINASE) (DGK- BETA) (DAG KINASE BETA) (90 KDA DIACYLGLYCEROL KINASE) homolog [Rattus nor |
KLA | .92 |
.92 |
.98 |
.93 |
1.01 |
1.06 |
1.00 |
| ATP | 1.03 |
1.05 |
.97 |
1.00 |
.95 |
1.03 |
.99 |
| KLA/ATP | 1.00 |
1.07 |
1.02 |
.97 |
1.00 |
.96 |
.97 |
|
Dgkb |  |
AK083222 |
adult male hippocampus cDNA, RIKEN full-length enriched library, clone:C630029D13 product:DIACYLGLYCEROL KINASE, BETA (EC 2.7.1.107) (DIGLYCERIDE KINASE) (DGK- BETA) (DAG KINASE BETA) (90 KDA DIACYLGLYCEROL KINASE) homolog [Rattus norvegi |
KLA | 1.02 |
1.02 |
1.12 |
1.01 |
1.00 |
1.05 |
.99 |
| ATP | .97 |
1.01 |
1.06 |
.95 |
1.07 |
1.03 |
1.03 |
| KLA/ATP | .95 |
.99 |
1.05 |
1.02 |
1.04 |
.96 |
1.06 |
|
Dgkb |  |
AK122355 |
mRNA for mKIAA0718 protein [AK122355] |
KLA | 1.03 |
.96 |
1.11 |
1.02 |
.95 |
.94 |
.97 |
| ATP | 1.00 |
.99 |
1.09 |
1.01 |
1.02 |
.96 |
.95 |
| KLA/ATP | .97 |
1.00 |
1.05 |
1.03 |
.95 |
1.02 |
.95 |
|
Dgkb |  |
NM_178681 |
diacylglycerol kinase, beta (Dgkb), mRNA [NM_178681] |
KLA | 1.05 |
1.08 |
1.03 |
1.04 |
.94 |
1.01 |
1.04 |
| ATP | 1.04 |
1.02 |
1.04 |
.95 |
1.01 |
1.03 |
1.05 |
| KLA/ATP | 1.09 |
.95 |
1.00 |
1.03 |
1.06 |
1.05 |
1.05 |
|
Dgkd |  |
AK076439 |
0 day neonate head cDNA, RIKEN full-length enriched library, clone:4832425N18 product:DIACYLGLYCEROL KINASE, DELTA (EC 2.7.1.107) (DIGLYCERIDE KINASE) (DGK-DELTA) (DAG KINASE DELTA) (130 KDA DIACYLGLYCEROL KINASE) (FRAGMENT) homolog [Homo |
KLA | .43 |
.42 |
.38 |
.38 |
.44 |
.36 |
.28 |
| ATP | 1.08 |
1.06 |
.96 |
1.28 |
1.01 |
.42 |
.25 |
| KLA/ATP | .42 |
.41 |
.38 |
.39 |
.46 |
.40 |
.23 |
|
Dgkd |  |
AK172901 |
mRNA for mKIAA0145 protein [AK172901] |
KLA | .27 |
.25 |
.22 |
.22 |
.23 |
.23 |
.22 |
| ATP | .87 |
.79 |
.81 |
.66 |
.58 |
.34 |
.31 |
| KLA/ATP | .22 |
.22 |
.19 |
.15 |
.20 |
.22 |
.15 |
|
Dgke |  |
NM_019505 |
diacylglycerol kinase, epsilon (Dgke), mRNA [NM_019505] |
KLA | 1.17 |
1.16 |
1.09 |
.92 |
.86 |
.99 |
1.25 |
| ATP | 1.02 |
1.01 |
.92 |
.79 |
.99 |
1.14 |
1.10 |
| KLA/ATP | 1.19 |
1.16 |
.98 |
.87 |
.97 |
1.05 |
.88 |
|
Dgkg |  |
AK089261 |
NOD-derived CD11c +ve dendritic cells cDNA, RIKEN full-length enriched library, clone:F630107L03 product:SIMILAR TO DIACYLGLYCEROL KINASE 3 (GAMMA) homolog [Mus musculus], full insert sequence. [AK089261] |
KLA | .95 |
.91 |
.97 |
.98 |
.97 |
.93 |
.96 |
| ATP | 1.04 |
1.02 |
.96 |
.93 |
.98 |
.89 |
.88 |
| KLA/ATP | 1.02 |
.99 |
.92 |
.86 |
.95 |
.92 |
.90 |
|
Dgkg |  |
NM_138650 |
diacylglycerol kinase, gamma (Dgkg), mRNA [NM_138650] |
KLA | .65 |
.64 |
.62 |
.78 |
.86 |
.68 |
.53 |
| ATP | .92 |
.99 |
1.04 |
.83 |
.67 |
.71 |
.55 |
| KLA/ATP | .60 |
.66 |
.66 |
.65 |
.84 |
1.00 |
.59 |
|
Dgkh |  |
AK031069 |
13 days embryo forelimb cDNA, RIKEN full-length enriched library, clone:5930402B05 product:DIACYLGLYCEROL KINASE, DELTA (EC 2.7.1.107) (DIGLYCERIDE KINASE) (DGK- DELTA) (DAG KINASE DELTA) (130 KDA DIACYLGLYCEROL KINASE) (DIACYLGLYCEROL KI |
KLA | 3.02 |
2.91 |
2.42 |
2.25 |
1.93 |
1.46 |
1.40 |
| ATP | 1.04 |
1.08 |
1.10 |
1.28 |
1.46 |
1.35 |
.98 |
| KLA/ATP | 3.66 |
4.04 |
3.53 |
1.88 |
1.69 |
1.34 |
1.47 |
|
Dgkh |  |
NM_001081336 |
diacylglycerol kinase, eta (Dgkh), mRNA [NM_001081336] |
KLA | 6.71 |
7.34 |
7.44 |
7.69 |
6.90 |
4.13 |
3.15 |
| ATP | .98 |
.96 |
1.02 |
1.20 |
2.01 |
3.95 |
2.09 |
| KLA/ATP | 6.79 |
7.17 |
6.53 |
7.03 |
4.73 |
5.21 |
5.62 |
|
Dgki |  |
AK086550 |
15 days embryo head cDNA, RIKEN full-length enriched library, clone:D930036J18 product:DIACYLGLYCEROL KINASE, IOTA (EC 2.7.1.107) (DIGLYCERIDE KINASE) (DGK- IOTA) (DAG KINASE IOTA) homolog [Homo sapiens], full insert sequence. [AK086550] |
KLA | 1.03 |
1.00 |
.96 |
1.07 |
1.00 |
1.08 |
.95 |
| ATP | 1.06 |
.99 |
1.02 |
.96 |
.98 |
1.02 |
1.03 |
| KLA/ATP | .99 |
.99 |
.99 |
.97 |
.99 |
.92 |
.99 |
|
Dgki |  |
NM_001081206 |
diacylglycerol kinase, iota (Dgki), mRNA [NM_001081206] |
KLA | .99 |
.96 |
.89 |
.99 |
.92 |
.98 |
1.02 |
| ATP | 1.00 |
1.01 |
.95 |
1.00 |
.95 |
.90 |
1.02 |
| KLA/ATP | .91 |
.86 |
1.02 |
.99 |
1.02 |
.90 |
.98 |
|
Dgkq |  |
NM_199011 |
diacylglycerol kinase, theta (Dgkq), mRNA [NM_199011] |
KLA | 1.09 |
.95 |
1.05 |
.98 |
.93 |
.96 |
1.11 |
| ATP | .99 |
.78 |
.66 |
.44 |
.99 |
1.04 |
1.23 |
| KLA/ATP | .98 |
.73 |
.66 |
.47 |
.67 |
.89 |
1.15 |
|
Dgkz |  |
NM_138306 |
diacylglycerol kinase zeta (Dgkz), mRNA [NM_138306] |
KLA | .21 |
.22 |
.23 |
.29 |
.56 |
1.23 |
1.39 |
| ATP | 1.08 |
1.25 |
.90 |
1.22 |
.85 |
.57 |
1.44 |
| KLA/ATP | .23 |
.22 |
.18 |
.31 |
.60 |
.80 |
1.45 |
|
Gk2 |  |
NM_010294 |
glycerol kinase 2 (Gk2), mRNA [NM_010294] |
KLA | 1.26 |
1.28 |
1.65 |
1.55 |
1.96 |
1.59 |
1.41 |
| ATP | .99 |
1.02 |
1.00 |
1.17 |
1.20 |
1.63 |
1.06 |
| KLA/ATP | 1.39 |
1.49 |
1.34 |
1.36 |
1.21 |
1.45 |
1.30 |
|
Gla |  |
NM_013463 |
galactosidase, alpha (Gla), mRNA [NM_013463] |
KLA | .91 |
.95 |
1.02 |
.93 |
1.02 |
1.35 |
1.99 |
| ATP | 1.06 |
1.22 |
1.08 |
1.49 |
1.31 |
1.44 |
3.32 |
| KLA/ATP | 1.01 |
1.05 |
.89 |
1.54 |
1.26 |
1.98 |
5.13 |
|
Gla |  |
U34071 |
alpha-galactosidase A mRNA, complete cds. [U34071] |
KLA | .99 |
.99 |
1.18 |
1.28 |
1.30 |
1.59 |
1.66 |
| ATP | 1.12 |
1.20 |
1.32 |
1.74 |
1.93 |
1.44 |
1.50 |
| KLA/ATP | 1.12 |
1.24 |
1.28 |
1.98 |
2.55 |
2.85 |
2.82 |
|
Glyctk |  |
NM_174846 |
glycerate kinase (Glyctk), transcript variant 1, mRNA [NM_174846] |
KLA | .98 |
1.05 |
1.12 |
1.07 |
1.13 |
1.16 |
1.11 |
| ATP | 1.04 |
1.07 |
.93 |
.93 |
.72 |
.97 |
1.22 |
| KLA/ATP | 1.02 |
1.02 |
.94 |
.89 |
.82 |
1.00 |
1.26 |
|
Gpam |  |
NM_008149 |
glycerol-3-phosphate acyltransferase, mitochondrial (Gpam), nuclear gene encoding mitochondrial protein, mRNA [NM_008149] |
KLA | 1.04 |
.97 |
1.00 |
1.04 |
.90 |
.96 |
1.00 |
| ATP | .98 |
1.18 |
1.10 |
.95 |
.70 |
.98 |
1.37 |
| KLA/ATP | 1.03 |
1.06 |
1.05 |
1.01 |
.79 |
.89 |
1.00 |
|
Gyk |  |
AK037633 |
16 days neonate thymus cDNA, RIKEN full-length enriched library, clone:A130030N17 product:unclassifiable, full insert sequence [AK037633] |
KLA | 5.44 |
4.98 |
5.36 |
4.61 |
4.88 |
2.89 |
1.97 |
| ATP | 1.17 |
1.65 |
4.22 |
2.33 |
6.88 |
2.27 |
1.07 |
| KLA/ATP | 5.99 |
9.29 |
15.97 |
4.69 |
3.09 |
3.74 |
2.06 |
|
Gyk |  |
AK086200 |
15 days embryo head cDNA, RIKEN full-length enriched library, clone:D930012N15 product:glycerol kinase, full insert sequence. [AK086200] |
KLA | 1.16 |
1.08 |
1.12 |
1.03 |
1.02 |
1.07 |
.98 |
| ATP | .93 |
1.01 |
1.12 |
.95 |
1.14 |
.96 |
.98 |
| KLA/ATP | 1.23 |
1.24 |
1.22 |
.95 |
1.10 |
.96 |
1.06 |
|
Gyk |  |
NM_008194 |
glycerol kinase (Gyk), transcript variant 1, mRNA [NM_008194] |
KLA | 2.56 |
2.95 |
3.62 |
4.16 |
5.93 |
5.02 |
2.77 |
| ATP | 1.04 |
1.19 |
1.02 |
1.51 |
2.16 |
4.68 |
1.09 |
| KLA/ATP | 2.65 |
2.96 |
2.71 |
4.15 |
2.62 |
4.18 |
3.09 |
|
Gyk |  |
NM_212444 |
glycerol kinase (Gyk), transcript variant 2, mRNA [NM_212444] |
KLA | 3.95 |
4.35 |
5.39 |
5.59 |
8.90 |
6.88 |
3.32 |
| ATP | 1.12 |
1.38 |
1.20 |
1.70 |
2.32 |
4.01 |
.95 |
| KLA/ATP | 3.99 |
4.03 |
4.00 |
5.56 |
2.86 |
3.73 |
3.14 |
|
Lipc |  |
NM_008280 |
lipase, hepatic (Lipc), mRNA [NM_008280] |
KLA | 1.00 |
1.01 |
.96 |
.99 |
1.01 |
1.06 |
1.05 |
| ATP | 1.02 |
1.03 |
1.15 |
.98 |
.93 |
1.03 |
.89 |
| KLA/ATP | 1.04 |
.92 |
1.07 |
.98 |
.99 |
.93 |
1.00 |
|
Lipf |  |
NM_026334 |
lipase, gastric (Lipf), mRNA [NM_026334] |
KLA | .98 |
1.00 |
1.09 |
1.07 |
1.04 |
1.12 |
1.11 |
| ATP | .96 |
.98 |
1.02 |
1.03 |
1.00 |
.99 |
1.05 |
| KLA/ATP | 1.03 |
1.05 |
.99 |
1.03 |
1.04 |
1.08 |
1.05 |
|
Lipg |  |
NM_010720 |
lipase, endothelial (Lipg), mRNA [NM_010720] |
KLA | 10.93 |
11.98 |
13.48 |
13.21 |
13.64 |
13.36 |
3.84 |
| ATP | 1.02 |
.97 |
1.44 |
1.72 |
1.38 |
1.91 |
1.52 |
| KLA/ATP | 11.30 |
13.74 |
13.52 |
14.68 |
10.21 |
9.64 |
10.43 |
|
Lpin1 |  |
AF180471 |
Lpin1 (Kiaa0188) mRNA, complete cds [AF180471] |
KLA | .26 |
.24 |
.29 |
.31 |
.26 |
.25 |
.24 |
| ATP | 1.23 |
.96 |
1.11 |
.97 |
.82 |
.43 |
.62 |
| KLA/ATP | .27 |
.25 |
.42 |
.37 |
.49 |
.34 |
.22 |
|
Lpin1 |  |
NM_015763 |
lipin 1 (Lpin1), transcript variant 2, mRNA [NM_015763] |
KLA | .19 |
.19 |
.18 |
.20 |
.18 |
.16 |
.19 |
| ATP | 1.02 |
.99 |
1.06 |
.93 |
.70 |
.35 |
.70 |
| KLA/ATP | .18 |
.17 |
.27 |
.25 |
.30 |
.25 |
.16 |
|
Lpin3 |  |
NM_022883 |
lipin 3 (Lpin3), mRNA [NM_022883] |
KLA | .99 |
.98 |
1.06 |
1.04 |
1.01 |
.99 |
.99 |
| ATP | 1.03 |
1.01 |
1.02 |
.92 |
1.00 |
1.03 |
.91 |
| KLA/ATP | 1.03 |
.97 |
.99 |
.99 |
.92 |
.91 |
1.02 |
|
Lpl |  |
NM_008509 |
lipoprotein lipase (Lpl), mRNA [NM_008509] |
KLA | .81 |
.81 |
.89 |
.76 |
.77 |
.71 |
.76 |
| ATP | 1.10 |
1.07 |
.65 |
.45 |
.37 |
.24 |
.62 |
| KLA/ATP | .89 |
.90 |
.56 |
.40 |
.29 |
.21 |
.23 |
|
Lycat |  |
NM_001081071 |
lysocardiolipin acyltransferase (Lycat), mRNA [NM_001081071] |
KLA | 1.03 |
.96 |
1.02 |
.97 |
1.02 |
.94 |
.99 |
| ATP | 1.09 |
1.08 |
.99 |
.94 |
.75 |
.90 |
1.06 |
| KLA/ATP | 1.02 |
1.10 |
.98 |
.91 |
.73 |
.97 |
1.03 |
|
Mboat1 |  |
NM_153546 |
membrane bound O-acyltransferase domain containing 1 (Mboat1), mRNA [NM_153546] |
KLA | .55 |
.57 |
.44 |
.39 |
.23 |
.14 |
.12 |
| ATP | .86 |
.94 |
1.05 |
1.04 |
.90 |
.52 |
.14 |
| KLA/ATP | .53 |
.53 |
.55 |
.53 |
.46 |
.35 |
.12 |
|
Mboat2 |  |
AK031682 |
13 days embryo male testis cDNA, RIKEN full-length enriched library, clone:6030487B18 product:unclassifiable, full insert sequence [AK031682] |
KLA | .94 |
.98 |
.99 |
.97 |
.92 |
1.08 |
1.08 |
| ATP | 1.00 |
.99 |
1.05 |
1.01 |
1.03 |
1.01 |
1.07 |
| KLA/ATP | 1.02 |
1.06 |
.99 |
1.06 |
1.08 |
1.14 |
.96 |
|
Mboat2 |  |
NM_026037 |
membrane bound O-acyltransferase domain containing 2 (Mboat2), transcript variant 1, mRNA [NM_026037] |
KLA | .84 |
.87 |
.81 |
.81 |
.81 |
.83 |
.95 |
| ATP | 1.03 |
1.01 |
1.04 |
1.01 |
1.10 |
1.02 |
.88 |
| KLA/ATP | .89 |
.88 |
.98 |
.91 |
.89 |
1.01 |
1.11 |
|
Mgll |  |
NM_011844 |
monoglyceride lipase (Mgll), mRNA [NM_011844] |
KLA | .86 |
.83 |
.81 |
.85 |
.67 |
.57 |
.46 |
| ATP | 1.02 |
1.00 |
1.15 |
1.16 |
1.26 |
1.27 |
.74 |
| KLA/ATP | .90 |
.85 |
1.01 |
1.05 |
1.26 |
1.20 |
.71 |
|
Mm.22792 4 |  |
142373198 |
Unknown |
KLA | 1.61 |
1.61 |
1.22 |
1.43 |
1.87 |
1.90 |
1.75 |
| ATP | 1.08 |
1.06 |
1.09 |
2.61 |
2.93 |
1.89 |
2.18 |
| KLA/ATP | 1.40 |
1.68 |
1.35 |
1.68 |
1.51 |
1.39 |
2.31 |
|
Mm.24244
|  |
23956161 |
Unknown |
KLA | 1.04 |
1.00 |
.96 |
1.04 |
1.53 |
1.13 |
1.09 |
| ATP | 1.17 |
1.30 |
.97 |
1.10 |
1.09 |
1.26 |
1.10 |
| KLA/ATP | .92 |
1.07 |
.82 |
.97 |
.80 |
.96 |
.74 |
|
Mm.28873
|  |
110431340 |
Unknown |
KLA | .79 |
.72 |
.69 |
.71 |
.44 |
.32 |
.37 |
| ATP | .89 |
.88 |
1.17 |
.98 |
1.11 |
.98 |
.73 |
| KLA/ATP | .67 |
.72 |
.87 |
.74 |
.75 |
.53 |
.30 |
|
Mm.32919 4 |  |
124486721 |
Unknown |
KLA | 1.02 |
.91 |
.92 |
.99 |
.85 |
.96 |
.84 |
| ATP | .97 |
.92 |
1.29 |
.82 |
.56 |
1.00 |
.95 |
| KLA/ATP | .90 |
.98 |
1.13 |
.79 |
.71 |
1.06 |
.84 |
|
Mm.41173 7 |  |
124486740 |
Unknown |
KLA | 6.95 |
6.26 |
6.49 |
5.66 |
6.34 |
2.93 |
3.01 |
| ATP | 1.18 |
1.40 |
1.03 |
1.27 |
1.96 |
1.87 |
1.53 |
| KLA/ATP | 6.62 |
7.00 |
6.07 |
6.81 |
2.75 |
2.22 |
2.84 |
|
Mm.44250 5 |  |
124487070 |
Unknown |
KLA | .93 |
.96 |
1.03 |
1.01 |
.97 |
.93 |
1.17 |
| ATP | 1.04 |
.91 |
.96 |
.96 |
.99 |
.89 |
.96 |
| KLA/ATP | .95 |
.89 |
.70 |
1.01 |
.95 |
1.00 |
.96 |
|
Pnlip |  |
AK007357 |
10 day old male pancreas cDNA, RIKEN full-length enriched library, clone:1810007A24 product:PANCREATIC TRIGLYCERIDE LIPASE (FRAGMENT) homolog [Rattus norvegicus], full insert sequence. [AK007357] |
KLA | .95 |
1.03 |
1.02 |
1.02 |
1.04 |
1.06 |
1.10 |
| ATP | 1.05 |
1.00 |
.95 |
1.10 |
1.00 |
1.03 |
1.02 |
| KLA/ATP | 1.02 |
1.00 |
.89 |
1.09 |
1.09 |
1.06 |
1.06 |
|
Pnlip |  |
NM_026925 |
pancreatic lipase (Pnlip), mRNA [NM_026925] |
KLA | 1.04 |
.97 |
1.04 |
1.00 |
1.02 |
.99 |
.97 |
| ATP | 1.04 |
1.04 |
1.04 |
.96 |
.95 |
1.02 |
.97 |
| KLA/ATP | .99 |
.95 |
.97 |
.99 |
.96 |
.93 |
1.00 |
|
Pnliprp1
|  |
NM_018874 |
pancreatic lipase related protein 1 (Pnliprp1), mRNA [NM_018874] |
KLA | .99 |
.95 |
.96 |
.99 |
.94 |
.96 |
1.01 |
| ATP | 1.00 |
1.00 |
.98 |
.96 |
.99 |
.87 |
1.09 |
| KLA/ATP | 1.01 |
1.06 |
1.01 |
1.02 |
1.03 |
.96 |
.92 |
|
Pnliprp2
|  |
NM_011128 |
pancreatic lipase-related protein 2 (Pnliprp2), mRNA [NM_011128] |
KLA | 1.01 |
.97 |
1.02 |
1.07 |
1.08 |
.98 |
1.00 |
| ATP | 1.05 |
1.08 |
.98 |
1.02 |
1.00 |
1.00 |
1.02 |
| KLA/ATP | 1.05 |
1.04 |
.96 |
.99 |
1.01 |
1.03 |
1.05 |
|
Pnpla2 |  |
NM_025802 |
patatin-like phospholipase domain containing 2 (Pnpla2), mRNA [NM_025802] |
KLA | 1.18 |
1.27 |
1.25 |
1.09 |
1.15 |
1.14 |
1.19 |
| ATP | 1.05 |
1.17 |
1.05 |
1.82 |
1.47 |
1.41 |
1.10 |
| KLA/ATP | 1.34 |
1.41 |
1.13 |
1.96 |
1.63 |
1.83 |
1.72 |
|
Pnpla3 |  |
NM_054088 |
patatin-like phospholipase domain containing 3 (Pnpla3), mRNA [NM_054088] |
KLA | .88 |
.99 |
1.04 |
.97 |
1.00 |
.91 |
1.03 |
| ATP | .95 |
1.03 |
1.05 |
1.03 |
1.01 |
.93 |
.99 |
| KLA/ATP | 1.02 |
1.05 |
1.00 |
.94 |
.95 |
.98 |
.95 |
|
Ppap2a |  |
NM_008903 |
phosphatidic acid phosphatase 2a (Ppap2a), transcript variant 2, mRNA [NM_008903] |
KLA | 2.62 |
2.86 |
4.01 |
5.61 |
7.84 |
10.88 |
16.35 |
| ATP | 1.01 |
1.02 |
1.09 |
1.28 |
1.27 |
2.38 |
1.44 |
| KLA/ATP | 2.78 |
2.78 |
2.99 |
3.43 |
2.85 |
3.59 |
6.59 |
|
Ppap2b |  |
NM_080555 |
phosphatidic acid phosphatase type 2B (Ppap2b), mRNA [NM_080555] |
KLA | 2.73 |
2.72 |
2.65 |
2.39 |
1.07 |
1.48 |
3.26 |
| ATP | .99 |
.97 |
1.60 |
2.76 |
18.64 |
27.23 |
9.19 |
| KLA/ATP | 2.69 |
2.80 |
4.36 |
4.20 |
14.33 |
15.32 |
17.91 |
|
Ppap2c |  |
NM_015817 |
phosphatidic acid phosphatase type 2c (Ppap2c), mRNA [NM_015817] |
KLA | .94 |
.88 |
.91 |
.79 |
.65 |
.46 |
.51 |
| ATP | 1.01 |
1.03 |
1.00 |
1.12 |
1.24 |
.90 |
.83 |
| KLA/ATP | .95 |
.93 |
.87 |
.95 |
.79 |
.63 |
.43 |
|